US diabetes care drugs market is anticipated to grow significantly over the forecast period. The key factor that drives the growth of the market includes the presence of a large pool of patients suffering from diabetes in the country. As per International Diabetes Federation, the number of adults suffering from diabetes in the country was 31.0 million peoples in 2019, which is projected to reach up to 34.4 million peoples in 2030, which is further predicted to reach 36.0 million in 2045.
Hence, the increased cases of diabetes are likely to prompt the demand for the proper treatment, which in turn, will provide growth opportunities for the US diabetes care drugs industry to grow in the near future.
Further, the government and other organizational support, to create awareness regarding the treatment and early diagnosis of the disease is also expected to propel the growth of the US diabetes care drugs market over the forecast period. Some of the awareness programs include the National Diabetes Prevention Program, American Diabetes Association, and other Diabetes Awareness and Prevention Campaigns.
Furthermore, the footprints of major players operating in the market such as Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., Sanofi SA, Takeda Pharmaceuticals Industries Ltd. among others support the market growth.
To Request a Sample of our Report on US Diabetes Care Drugs Market: https://www.omrglobal.com/request-sample/us-diabetes-care-drugs-market
Market Coverage
- Market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered- By Drug Class
- Country Covered- the US
- Competitive Landscape- Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Eli Lilly and Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., and Takeda Pharmaceuticals Industries Ltd
US Diabetes Care Drugs Market – Segmentation
By Drug Class
- Insulins
- Non-Insulin Injectable Drugs
- Oral Anti-Diabetic Drugs
- Combination Drugs
A full Report of US Diabetes Care Drugs Market is Available at: https://www.omrglobal.com/industry-reports/us-diabetes-care-drugs-market
Company Profiles
- AstraZeneca Plc
- Bayer AG
- Bausch Health Companies Inc.
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Mylan NV
- Nectar Therapeutics
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Sun Pharma Industries Ltd.
- Takeda Pharmaceuticals Industries Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
